Financing Agreements in the Biotechnology Industry

28 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Senior Secured Super Priority Debtor-In-Possession Financing Agreement, dated as of November 13, 2024, by and among Gritstone bio, Inc., the lenders from time to time party...
Financing Agreements
Gritstone Oncology, Inc.
Biotechnology
DE
2024
First Amendment to Financing Agreement dated as of May 22, 2023 by and among Blueprint Medicines Corporation, the lenders party thereto, and TAO Talents LLC, as Administrative...
Financing Agreements
Blueprint Medicines Corp
Biotechnology
NY
2023
First Amendment to Revenue Interest Financing Agreement, dated August 4, 2022, by and between the Company, the purchasers party thereto and Oaktree Fund Administration, LLC, as...
Financing Agreements
BioXcel Therapeutics, Inc.
Biotechnology
2023
Secured Superpriority Debtor-In-Possession Financing Agreement, dated as of January 6, 2023, by and among the Company, as borrower, Clovis Ireland and Clovis UK, as guarantors,...
Financing Agreements
Clovis Oncology, Inc.
Biotechnology
NY
2023
Omnibus Amendment #1 to Financing Agreements by and between the Registrant and the investor who is a signatory thereto
Financing Agreements
Intrinsic Medicine, Inc.
Biotechnology
2022
Amendment No. 4 to Financing Agreement, dated as of December 28, 2021, by and between Biohaven Pharmaceuticals Holding Company Ltd., Biohaven Pharmaceuticals, Inc., the guarantors...
Financing Agreements
Biohaven Pharmaceutical Holding Co Ltd.
Biotechnology
NY
2022
Amendment No. 3 and Limited Consent to Financing Agreement, dated November 9, 2021, by and between Biohaven Pharmaceuticals Holding Company Ltd., Biohaven Pharmaceuticals, Inc.,...
Financing Agreements
Biohaven Pharmaceutical Holding Co Ltd.
Biotechnology
NY
2021
Master Equipment Financing Agreement, dated March 29, 2021, by and between Trinity Capital Inc. and GreenLight Biosciences, Inc
Financing Agreements
Environmental Impact Acquisition Corp
Biotechnology
2021
Project Financing Agreement, dated August 12, 2020, by and between Windtree and Lees Pharmaceutical (HK) Ltd
Financing Agreements
WINDTREE THERAPEUTICS INC
Biotechnology
NY
2020
Financing Agreement with RB Capital Partners, Inc
Financing Agreements
Sunshine Biopharma, Inc
Biotechnology
2020
Revenue Interest Financing Agreement
Financing Agreements
Athenex, Inc.
Biotechnology
DE
2020
Form of Financing Lock-Up Agreement, by and among Rexahn, Ocuphire, and the investors party thereto
Financing Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2020
Form of Financing Lock-Up Agreement, by and among Rexahn, Ocuphire, and the investors party thereto
Financing Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2020
Technology Acquisition and Financing Agreement dated May 8, 2020
Financing Agreements
PREMIER BIOMEDICAL INC
Biotechnology
2020
Revenue Interest Financing Agreement, dated September 14, 2019, between the Registrant and HealthCare Royalty Partners III, L.P, and HealthCare Royalty Partners IV, L.P
Financing Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2019
Financing Agreement, dated as of May 1, 2019 among Clovis Oncology, Inc. (the Company), certain subsidiaries of the Company named therein, as Guarantors, the Lenders from time to...
Financing Agreements
Clovis Oncology, Inc.
Biotechnology
DE
2019
Equity Financing Agreement dated September 10, 2018 by and between Sunshine Biopharma, Inc. and GHS Investments, LLC
Financing Agreements
Sunshine Biopharma, Inc
Biotechnology
NY
2018
Equity Financing Agreement dated February 22, 2017 with GHS Investments, LLC
Financing Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2017
EQUITY FINANCING AGREEMENT
Financing Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2016
Convertible Preferred Financing
Financing Agreements
Adhera Therapeutics, Inc.
Biotechnology
NY
2014
SIDE AGREEMENT TO INVESTOR FINANCING AGREEMENT
Financing Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
DE
2012
INVESTOR FINANCING AGREEMENT by and among BIOCRYST PHARMACEUTICALS, INC. and THE INVESTORS LISTED ON SCHEDULE 1 Dated as of October 17, 2012 TABLE OF CONTENTS
Financing Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
DE
2012
AMENDMENT NO. 3 TO THE STEP-UP EQUITY FINANCING AGREEMENT
Financing Agreements
CTI BIOPHARMA CORP
Biotechnology
2006
AMENDMENT NO. 2 TO THE STEP-UP EQUITY FINANCING AGREEMENT
Financing Agreements
CTI BIOPHARMA CORP
Biotechnology
2006
AMENDMENT NO. 1 TO THE STEP-UP EQUITY FINANCING AGREEMENT
Financing Agreements
CTI BIOPHARMA CORP
Biotechnology
2006
STEP-UP EQUITY FINANCING AGREEMENT Dated June 21, 2006
Financing Agreements
CTI BIOPHARMA CORP
Biotechnology
2006
Recapitalized the Company by securing over $55 million in equity financing
Financing Agreements
Spectrum Pharmaceuticals, Inc.
Biotechnology
2005
[CONFIDENTIAL TREATMENT REQUESTED] FINANCING AGREEMENT
Financing Agreements
CTI BIOPHARMA CORP
Biotechnology
WA
2005
[CONFIDENTIAL TREATMENT REQUESTED] FINANCING AGREEMENT
Financing Agreements
CTI BIOPHARMA CORP
Biotechnology
WA
2004